Renal cancer

CTD - Clinical Trials Data

Abbreviations

Primary tumour

Liver

Ovary

Melanoma / Skin

Terms

AVOREN

BEVA+INF vs PLB+INF

L1

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma

First author: Bernard Escudier

CLEAR

LENV+PEMB vs suni

L1

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

First author: R. Motzer

CheckMate 025

NIVO vs ever

L2

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

First author: R.J. Motzer

CheckMate 214

NIVO+IPIL vs suni

L1

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

First author: R.J. Motzer

CheckMate 9ER

NIVO+CABO vs suni

L1

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

First author: T.K. Choueiri

JAVELIN Renal 101

AVEL+AXIT vs SUNI

L1

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

First author: Robert J. Motzer

KEYNOTE-426

PEMB+AXIT vs sunit

L1

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

First author: B.I. Rini

METEOR

CABO vs ever

L2

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

First author: T.K. Choueiri

Terms

© 2021 - 2024 | MedAgora Consulting srl